|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/39 | (2006.01) |
| C07K 16/28 | (2013.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 14/78 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/705 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 14/71 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 14/47 | (2013.01) | ||
| C07K 14/78 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2319/70 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| C07K2318/20 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/2863 | (2013.01) |
| (11) | Number of the document | 3485901 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18197990.7 |
| Date of filing the European patent application | 2013-11-21 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261728906 P | 2012-11-21 | US | |
| 201261728914 P | 2012-11-21 | US | |
| 201261728912 P | 2012-11-21 | US | |
| 201361782550 P | 2013-03-14 | US | |
| 201361809541 P | 2013-04-08 | US |
| (72) |
ANDERSON, Mark , US
ATTAR, Ricardo , US
DIEM, Michael , US
HYUN, Linus , US
JACOBS, Steven , US
KING, Alastair , US
KLEIN, Donna , US
MOORES, Sheri , US
O'NEIL, Karyn , US
PICHA, Kristen , US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES |
| EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES |